Drug intelligence / Profile preview

D-Tryptophan

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

D-Tryptophan is a D-amino acid with diverse biological activities. It has been shown to promote skin wound healing, particularly in diabetic models, by modulating extracellular matrix remodeling through the upregulation of matrix metalloproteinases (MMP1, MMP3, MMP-9), influencing signaling pathways by upregulating Janus kinase 2 (JAK2) and mitogen-activated protein kinase (MAPK), reducing pro-inflammatory cytokines (tumor necrosis factor-α, interleukin-1β, interleukin-6), suppressing caspase-3, and enhancing angiogenesis via hypoxia-inducible factor-1α (HIF-1α) activation. Beyond wound healing, D-Tryptophan also exhibits antifungal activity against plant pathogenic fungi like Botrytis cinerea and Sclerotinia sclerotiorum, and can inhibit bacterial biofilm formation, specifically reducing avian pathogenic Escherichia coli biofilm. It is also recognized as a functional metabolite.

Other names
D-Trp
02

Targets

CASP3 (Caspase-3)HIF1A (Hypoxia-inducible factor 1-alpha)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)JAK2 (Janus kinase 2)MAPK3 (Mitogen-activated protein kinase 1)MMP1 (Matrix metalloproteinase-1)MMP3 (Matrix metalloproteinase-3)MMP9 (Matrix metalloproteinase-9)TNFA (Tumor necrosis factor alpha (soluble))MEK

Beyond the preview

Go deeper on D-Tryptophan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-Tryptophan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call